Quest Diagnostics Profit Margin 2011-2025 | DGX
Current and historical gross margin, operating margin and net profit margin for Quest Diagnostics (DGX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Quest Diagnostics net profit margin as of September 30, 2025 is 8.91%.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $20.786B | $9.872B |
| Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Encompass Health (EHC) | United States | $11.551B | 22.20 |
| Elanco Animal Health (ELAN) | United States | $10.956B | 22.97 |
| DaVita (DVA) | United States | $8.726B | 12.74 |
| Chemed (CHE) | United States | $6.339B | 22.27 |
| RadNet (RDNT) | United States | $5.744B | 195.92 |
| Option Care Health (OPCH) | United States | $4.610B | 19.62 |
| LifeStance Health (LFST) | United States | $2.505B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.102B | 21.70 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.838B | 23.16 |
| Astrana Health (ASTH) | United States | $1.326B | 124.00 |
| U.S Physical Therapy (USPH) | United States | $1.103B | 27.90 |
| Atai Beckley N.V (ATAI) | Germany | $1.012B | 0.00 |
| Pennant (PNTG) | United States | $0.873B | 29.02 |
| Daxor (DXR) | United States | $0.062B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.060B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |